A Study of Atezolizumab (Tecentriq) in Combination With Bevacizumab to Investigate Safety and Efficacy in Patients With Unresectable Hepatocellular Carcinoma Not Previously Treated With Systemic Therapy-Amethista
Clinical trial NCT04487067 · COMPLETED
Trial details
- NCT number
- NCT04487067
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2024-08-13
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.